📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Verteporfin selectively kills hypoxic glioma cells through iron-binding and increased production of reactive oxygen species. (2018)

First Author: Eales KL

Attributed to: A Programme of Technology, Astrophysics and Cosmology in Cardiff 2012-14 funded by STFC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-018-32727-1

PubMed Identifier: 30254296

Publication URI: http://europepmc.org/abstract/MED/30254296

Type: Journal Article/Review

Volume: 8

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322